Healthequity Scr Sa

Director · Spanish companies register · 3 companies

Companies :
3 (1 current, 2 former)
Linked companies :
PEPTOMYC SL, GLYCARDIAL DIAGNOSTICS S.L, MINORYX THERAPEUTICS SL

Summary

Healthequity Scr Sa appears in the Spanish commercial register as a director of 3 companies, 1 current and 2 former. Currently Consejero of PEPTOMYC SL (Barcelona) since 8 July 2016. PEPTOMYC SL is based in Barcelona and operates in Otra investigación y desarrollo experimental en ciencias naturales y técnicas (CNAE 7219) — Sociedad Limitada (SL), an active company, incorporated on 16 December 2014, share capital of €164,346. The earliest registered mandate dates from 30 July 2015, at MINORYX THERAPEUTICS SL; the most recent began on 4 December 2017. The companies are registered in Barcelona. The boards of these companies also include Bart de Leeuw, Claude Nicaise, Khalid Islam and 10 others.

Offices held

Consejero

Commercial registries

Barcelona

Companies · current (1)

PEPTOMYC SLCurrent

Consejero since 08/07/2016

Active · Otra investigación y desarrollo experimental en ciencias naturales y técnicas (CNAE 7219) · Barcelona · Sociedad Limitada (SL) · incorporated 16/12/2014 · capital €164,346 · 23 BORME filings

Corporate purpose: LA REALIZACION Y DESARROLLO DE ESTUDIOS Y PROYECTOS DE INVESTIGACION CIENTIFICA Y TECNICA EN EL AMBITO DE LAS ENFERMEDADES ONCOLOGICAS Y TUMORALES.

B66430653 · Barcelona

Companies · former (2)

GLYCARDIAL DIAGNOSTICS S.LFormer

Former Consejero · from 04/12/2017 to 13/04/2023

Active · incorporated 05/10/2017 · capital €7,830 · 13 BORME filings

Corporate purpose: LA INVESTIGACION, DESARROLLO Y COMERCIALIZACION DE MOLECULAS, DISPOSITIVOS MEDICOS, DISPOSITIVOS DE DIAGNOSTICO Y OTROS SERVICIOS RELACIONADOS CON LA BIOTECNOLOGIA Y LA SALUD HUMANA Y ANIMAL, ETC.

B509616 · Barcelona

MINORYX THERAPEUTICS SLFormer

Former Consejero · from 30/07/2015 to 10/09/2015

Active · Investigación y desarrollo experimental en biotecnología (CNAE 7211) · Mataro · Sociedad Limitada (SL) · incorporated 17/10/2011 · capital €1,707,355 · 48 BORME filings

Corporate purpose: LA REALIZACION DE ACTIVIDADES DE INVESTIGACION,DESARROLLO E INNOVACION EN EL AMBITO TECNICO SANITARIO Y,EN PARTICULAR,DE LA BIOTECNOLOGIA.LA REALIZACION DE ESTUDIOS CIENTIFICOS Y TECNICOS PARA EL DESCUBRIMIENTO,DISEÑO,ETC.

B65648156 · Barcelona

Timeline (5)

  1. 13/04/2023Ceased as Consejero of GLYCARDIAL DIAGNOSTICS S.L · Barcelona
  2. 04/12/2017Appointed Consejero of GLYCARDIAL DIAGNOSTICS S.L · Barcelona
  3. 08/07/2016Appointed Consejero of PEPTOMYC SL · Barcelona
  4. 10/09/2015Ceased as Consejero of MINORYX THERAPEUTICS SL · Barcelona
  5. 30/07/2015Appointed Consejero of MINORYX THERAPEUTICS SL · Barcelona

Co-directors (13)

MINORYX THERAPEUTICS SL
PEPTOMYC SL
GLYCARDIAL DIAGNOSTICS S.L

Network map

10 nodes Person Company
healthequity-scr-saPEPTOMYC SLPEPTOMYC SLDNAS DI NEPI ADVISORY SERVICES GMBHDNAS DI NEPI ADVISOR…ALEGRE RIBALTA OSCARALEGRE RIBALTA OSCARVENGOHECHEA DELGADO XAVIERVENGOHECHEA DELGADO …EDOARDO NEGRONIEDOARDO NEGRONIJESUS MARTIN GARCIAJESUS MARTIN GARCIAVALUE MANAGEMENT GROUP SARLVALUE MANAGEMENT GRO…SELWYN HOSELWYN HOVENDRELL RIUS MONTSERRATVENDRELL RIUS MONTSE…

Identity matched by name · homonyms possible.